| NCT04256616 |
Immunogenic Cell Death as a Novel Mechanism of Mitomycin C Activity in Bladder Cancer |
https://ClinicalTrials.gov/show/NCT04256616 |
Recruiting |
Istituto Clinico Humanitas |
2020-09-01 |
| NCT03327883 |
Retrospective Review of FDG PET MRI Management of Patients With Muscle Invasive Bladder Cancer |
https://ClinicalTrials.gov/show/NCT03327883 |
Completed |
National Institutes of Health Clinical Center (CC) |
2018-10-16 |
| NCT03325231 |
Factors Influencing Patient Choice of Bladder Reconstruction Following Radical Cystectomy |
https://ClinicalTrials.gov/show/NCT03325231 |
Recruiting |
Swansea University |
2021-09-30 |
| NCT03193541 |
A Novel Multiplex ELISA Assay for Evaluating Patients With Microscopic Hematuria for Bladder Cancer |
https://ClinicalTrials.gov/show/NCT03193541 |
Recruiting |
Cedars-Sinai Medical Center |
2021-12-30 |
| NCT03193528 |
A Novel Multiplex ELISA Assay for Evaluating Patients With Gross Hematuria for Bladder Cancer |
https://ClinicalTrials.gov/show/NCT03193528 |
Recruiting |
Cedars-Sinai Medical Center |
2021-12-30 |
| NCT03193515 |
A Novel Multiplex ELISA Assay for Surveilling Patients With History of Bladder Cancer |
https://ClinicalTrials.gov/show/NCT03193515 |
Recruiting |
Cedars-Sinai Medical Center |
2021-12-30 |
| NCT03156244 |
Using PROMIS as Part of Routine Clinical Care for Racially Diverse Prostate and Bladder Cancer Patients |
https://ClinicalTrials.gov/show/NCT03156244 |
Completed |
UNC Lineberger Comprehensive Cancer Center |
2018-05-05 |
| NCT03133286 |
Radiotherapy Assessments During Intervention ANd Treatment (RADIANT) |
https://ClinicalTrials.gov/show/NCT03133286 |
Recruiting |
DxTerity Diagnostics |
2019-09-06 |
| NCT03125460 |
Clinical Evaluation of a Test for Monitoring the Recurrence of Bladder Cancer |
https://ClinicalTrials.gov/show/NCT03125460 |
Completed |
Cepheid |
2019-02-28 |
| NCT03122964 |
Multi Institutional Study in Patient Presenting With Hematuria |
https://ClinicalTrials.gov/show/NCT03122964 |
Active, not recruiting |
MDx Health |
2020-02-28 |
| NCT03066310 |
Urine-DNA Biomarkers in Detecting Bladder Cancer |
https://ClinicalTrials.gov/show/NCT03066310 |
Enrolling by invitation |
Xiangya Hospital of Central South University |
2019-10-31 |
| NCT03065725 |
Early Versus Late FDG-PET/CT in Bladder Cancer |
https://ClinicalTrials.gov/show/NCT03065725 |
Active, not recruiting |
Aarhus University Hospital |
2019-08-13 |
| NCT03063125 |
Hypogonadism in Bladder Cancer |
https://ClinicalTrials.gov/show/NCT03063125 |
Active, not recruiting |
University of Kansas Medical Center |
2020-05-30 |
| NCT03029663 |
Complications of Transurethral Resection of the Bladder Tumour |
https://ClinicalTrials.gov/show/NCT03029663 |
Completed |
Medical University of Warsaw |
2017-09-30 |
| NCT03013894 |
Confocal Laser Endomicroscopy in the Lower Urinary Tract |
https://ClinicalTrials.gov/show/NCT03013894 |
Completed |
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) |
2017-10-31 |
| NCT02957370 |
Molecular Biosensors for Detection of Bladder Cancer |
https://ClinicalTrials.gov/show/NCT02957370 |
Recruiting |
University of California, Irvine |
2019-06-30 |
| NCT02857634 |
Confocal Microscopy Dual Band in the Management of Bladder Cancer |
https://ClinicalTrials.gov/show/NCT02857634 |
Completed |
Lille Catholic University |
2016-09-30 |
| NCT02781428 |
To Detect the Sensitivity of the UroMark Assay |
https://ClinicalTrials.gov/show/NCT02781428 |
Active, not recruiting |
University College, London |
2020-09-30 |
| NCT02756637 |
Neutrophil-to-Lymphocyte Ratio in Bladder Cancer: A Secondary Biomarker Analysis of SWOG 8710 |
https://ClinicalTrials.gov/show/NCT02756637 |
Completed |
Abramson Cancer Center of the University of Pennsylvania |
2016-10-31 |
| NCT02745301 |
Urinary Biomarkers in the Detection of Urothelial Carcinoma of the Bladder |
https://ClinicalTrials.gov/show/NCT02745301 |
Completed |
Vanderbilt University Medical Center |
2018-01-31 |
| NCT02735512 |
MDSC Clinical Assay in Finding and Monitoring Cancer Cells in Blood and Urine Samples From Patients With or Without Localized or Metastatic Bladder Cancer |
https://ClinicalTrials.gov/show/NCT02735512 |
Recruiting |
University of Southern California |
2020-03-01 |
| NCT02695121 |
Cancer in Patients on Dapagliflozin and Other Antidiabetic Treatment |
https://ClinicalTrials.gov/show/NCT02695121 |
Recruiting |
AstraZeneca |
2025-02-28 |
| NCT01935466 |
Risk of Bladder Cancer in Type 2 Diabetes Patients With Pioglitazone Therapy “PROBE” |
https://ClinicalTrials.gov/show/NCT01935466 |
Recruiting |
Postgraduate Institute of Medical Education and Research |
2020-12-31 |
| NCT00341861 |
Interdisciplinary Case-Control Study of Bladder Cancer in Spain |
https://ClinicalTrials.gov/show/NCT00341861 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT00745355 |
Quality of Life in Patients With Bladder Cancer |
https://ClinicalTrials.gov/show/NCT00745355 |
Active, not recruiting |
Memorial Sloan Kettering Cancer Center |
2020-08-31 |
| NCT02538809 |
Novel mRNA-based Urine Test for Bladder Cancer in Spinal Cord Injury Individuals |
https://ClinicalTrials.gov/show/NCT02538809 |
Recruiting |
Swiss Paraplegic Centre Nottwil |
2021-12-31 |
| NCT02427321 |
Cystoscopic Imaging Collection and Enhancement pROject |
https://ClinicalTrials.gov/show/NCT02427321 |
Completed |
Biosignatures Limited |
2015-10-31 |
| NCT02400944 |
Determinants of Bladder Cancer Recurrence Study (The DETER Study) |
https://ClinicalTrials.gov/show/NCT02400944 |
Active, not recruiting |
Memorial Sloan Kettering Cancer Center |
2021-03-31 |
| NCT02381912 |
Sexual Function in Patients Suspected of Non-muscle Invasive Bladder Cancer |
https://ClinicalTrials.gov/show/NCT02381912 |
Completed |
Herlev Hospital |
2016-01-31 |
| NCT02345473 |
Detection and Clinical Significance of Circulating Cancer Cells in Patient Undergoing Radical Cystectomy |
https://ClinicalTrials.gov/show/NCT02345473 |
Completed |
Azienda Ospedaliero-Universitaria Consorziale |
2014-10-31 |
| NCT02328417 |
Enhanced Recovery After Radical Cystectomy Study |
https://ClinicalTrials.gov/show/NCT02328417 |
Completed |
Hospital Universitario Fundación Alcorcón |
2017-02-28 |
| NCT02217891 |
IFACT: Incidental Findings in Advanced Cancer Therapy |
https://ClinicalTrials.gov/show/NCT02217891 |
Active, not recruiting |
Memorial Sloan Kettering Cancer Center |
2021-08-31 |
| NCT02203136 |
Improving Clinical Staging for Muscle Invasive Bladder Cancer Through Molecular Profiling and Improved Imaging |
https://ClinicalTrials.gov/show/NCT02203136 |
Completed |
M.D. Anderson Cancer Center |
2019-05-16 |
| NCT02186925 |
A Prospective Study of Clinical Factors Affecting Disease Progression and Treatment Results of Patients With Tumors of the Prostate, Bladder and Kidney. |
https://ClinicalTrials.gov/show/NCT02186925 |
Recruiting |
Meir Medical Center |
2019-08-31 |
| NCT02113501 |
Optimized Treatment Strategy for HighGrade1 (HGT1) Bladder Cancer Based on Substaging: a Prospective Observational Cohort Study |
https://ClinicalTrials.gov/show/NCT02113501 |
Completed |
Hospital Universitari Vall d’Hebron Research Institute |
2013-12-31 |
| NCT02039310 |
Prediction of Impaired Survival in Elderly Bladder Cancer Patients Opting for Radical Cystectomy |
https://ClinicalTrials.gov/show/NCT02039310 |
Completed |
University of Michigan |
2015-12-31 |
| NCT03433924 |
An Epidemiologic Study on PD-L1 Expression Combined With Clinical Observation in the Chinese MIUBC Patients. |
https://ClinicalTrials.gov/show/NCT03433924 |
Recruiting |
AstraZeneca |
2023-05-29 |
| NCT01810445 |
Endoscopic Subsurface Optical Imaging for Cancer Detection |
https://ClinicalTrials.gov/show/NCT01810445 |
Completed |
University of California, Davis |
2011-08-31 |
| NCT01776138 |
Study of Outcomes After Surgery/Treatment to Treat Bladder Cancer |
https://ClinicalTrials.gov/show/NCT01776138 |
Recruiting |
UNC Lineberger Comprehensive Cancer Center |
2020-04-30 |
| NCT01706185 |
Incidence of Expression of Tumor Antigens in Cancer Tissue From Patients With Pathologically Demonstrated Bladder Cancer |
https://ClinicalTrials.gov/show/NCT01706185 |
Completed |
GlaxoSmithKline |
2008-01-15 |
| NCT01447199 |
The Molecular Predisposition to Hereditary Nonpolyposis Colon Cancer (HNPCC) |
https://ClinicalTrials.gov/show/NCT01447199 |
Active, not recruiting |
M.D. Anderson Cancer Center |
2020-09-30 |
| NCT01444456 |
Assessment of Quality of Life in Patients With Symptomatic Chemotherapy-induced Anaemia |
https://ClinicalTrials.gov/show/NCT01444456 |
Completed |
Amgen |
2013-08-31 |
| NCT04410302 |
Patient-Derived Xenografts to Reduce Cancer Health Disparities |
https://ClinicalTrials.gov/show/NCT04410302 |
Recruiting |
University of California, Davis |
2023-06-30 |
| NCT04406168 |
Assessment of Urinary Diversions Outcomes Post Radical Cystectomy in Asyut University Urology Hospital |
https://ClinicalTrials.gov/show/NCT04406168 |
Recruiting |
Assiut University |
2022-05-01 |
| NCT04385316 |
Clinical Study of Gastric Cancer, Colorectal Cancer and Bladder Cancer Based on Liquid Biopsy |
https://ClinicalTrials.gov/show/NCT04385316 |
Recruiting |
The First Affiliated Hospital with Nanjing Medical University |
2020-12-31 |
| NCT04334226 |
The Impact of Preoperative Urostomy Education on Patients and Families |
https://ClinicalTrials.gov/show/NCT04334226 |
Enrolling by invitation |
University of Kansas Medical Center |
2020-07-30 |
| NCT04314245 |
Diagnostic Evaluation of Urine DNA Methylation/Somatic Mutation Profiling for the Detection of Urothelial Carcinoma |
https://ClinicalTrials.gov/show/NCT04314245 |
Recruiting |
AnchorDx Medical Co., Ltd. |
2020-08-31 |
| NCT04310813 |
Microscopic-spectroscopic Examination for Urothelial Tissue Characterization |
https://ClinicalTrials.gov/show/NCT04310813 |
Completed |
Careggi Hospital |
2019-12-01 |
| NCT04282876 |
Influence of Hormone Treatment in Radiation Therapy for Bladder Cancer |
https://ClinicalTrials.gov/show/NCT04282876 |
Recruiting |
Aarhus University Hospital |
2022-02-01 |
| NCT04256122 |
Expression of Markers Related to Mitochondrial Functionality in Carcinoma of the Urinary Bladder: Comparative Retrospective Analysis Between Recurrent Tumors (“Non-responders”) and Non-recurrent Tumors (“Responders”) After Intravesical Treatment With Chemotherapy or Immunotherapy |
https://ClinicalTrials.gov/show/NCT04256122 |
Recruiting |
Istituto Clinico Humanitas |
2020-10-31 |
| NCT04228198 |
Protocol of the Italian Radical Cystectomy Registry |
https://ClinicalTrials.gov/show/NCT04228198 |
Recruiting |
University of Roma La Sapienza |
2020-01-01 |
| NCT04162704 |
EpiCheck and Short-term Intensive Chemoresection in NMIBC |
https://ClinicalTrials.gov/show/NCT04162704 |
Recruiting |
Aarhus University Hospital |
2020-10-31 |
| NCT04155359 |
Clinical Evaluation of the miR Sentinel BCaâ„¢ Test to Diagnose Bladder Cancer in Hematuria Patients |
https://ClinicalTrials.gov/show/NCT04155359 |
Recruiting |
miR Scientific LLC |
2022-12-31 |
| NCT04144270 |
The Importance of Muscle Function in Patients With Disseminated Bladder Cancer |
https://ClinicalTrials.gov/show/NCT04144270 |
Recruiting |
Rigshospitalet, Denmark |
2021-04-30 |
| NCT04089748 |
Basal Tumours in Bladder Cancer, Response to chemoTherapy |
https://ClinicalTrials.gov/show/NCT04089748 |
Recruiting |
University Hospital, Rouen |
2023-03-31 |
| NCT04053101 |
Role of FDG-PET CT in the Management of Muscle Invasive Bladder Cancer |
https://ClinicalTrials.gov/show/NCT04053101 |
Active, not recruiting |
Institut Bergonié |
2018-12-31 |
| NCT04036877 |
Mood Disorders Bladder Cancer |
https://ClinicalTrials.gov/show/NCT04036877 |
Recruiting |
University of Kansas Medical Center |
2021-07-31 |
| NCT03973671 |
Flemish Databank for Urothelial Cancer |
https://ClinicalTrials.gov/show/NCT03973671 |
Recruiting |
Universitaire Ziekenhuizen Leuven |
2024-03-31 |
| NCT03973307 |
UroX Biomarker Bladder Cancer Study |
https://ClinicalTrials.gov/show/NCT03973307 |
Recruiting |
East and North Hertfordshire NHS Trust |
2020-07-01 |
| NCT03933826 |
CISTO: Comparison of Intravesical Therapy and Surgery as Treatment Options for Bladder Cancer |
https://ClinicalTrials.gov/show/NCT03933826 |
Recruiting |
University of Washington |
2023-10-31 |
| NCT03896958 |
The PIONEER Initiative: Precision Insights On N-of-1 Ex Vivo Effectiveness Research Based on Individual Tumor Ownership (Precision Oncology) |
https://ClinicalTrials.gov/show/NCT03896958 |
Recruiting |
SpeciCare |
2021-03-12 |
| NCT03892031 |
Circulatory Function in Laparoscopic Radical Cystectomy for Bladder Cancer |
https://ClinicalTrials.gov/show/NCT03892031 |
Recruiting |
RenJi Hospital |
2019-12-31 |
| NCT03863028 |
Development and Validation of a Simulator-based Test in Transurethral Resection of Bladder Tumors |
https://ClinicalTrials.gov/show/NCT03863028 |
Completed |
Rigshospitalet, Denmark |
2018-09-21 |
| NCT03801954 |
Implementation of Nutrition Education Videos for Patients Undergoing Radical Cystectomy |
https://ClinicalTrials.gov/show/NCT03801954 |
Recruiting |
University of Kansas Medical Center |
2020-12-31 |
| NCT03789682 |
CD155 in Bladder Cancer |
https://ClinicalTrials.gov/show/NCT03789682 |
Recruiting |
Fudan University |
2023-01-01 |
| NCT03739177 |
Onco4D(TM) Biodynamic Chemotherapy Selection for Bladder Cancer Patients |
https://ClinicalTrials.gov/show/NCT03739177 |
Recruiting |
Animated Dynamics, Inc. |
2020-06-30 |
| NCT01264744 |
Detection of Chromosomal Aberrations in Urine Samples Using Fluorescent in Situ Hybridization (FISH) (UroVysion Test) |
https://ClinicalTrials.gov/show/NCT01264744 |
Completed |
Applied Spectral Imaging Ltd. |
2010-08-31 |
| NCT01236053 |
Cancer in Patients With Gabapentin (GPRD) |
https://ClinicalTrials.gov/show/NCT01236053 |
Completed |
GlaxoSmithKline |
2010-09-30 |
| NCT01166230 |
Longer-term Recurrence Rates in Patients With Bladder Cancer After Hexvix (Cysview)Fluorescence Cystoscopy/TURB |
https://ClinicalTrials.gov/show/NCT01166230 |
Completed |
Photocure |
2010-12-31 |
| NCT01135849 |
B-Receptor Signaling in Cardiomyopathy |
https://ClinicalTrials.gov/show/NCT01135849 |
Completed |
Stanford University |
2010-10-31 |
| NCT01090388 |
Bladder Cancer Patient-Reported Outcomes |
https://ClinicalTrials.gov/show/NCT01090388 |
Completed |
Baylor College of Medicine |
2011-08-31 |
| NCT01050504 |
Collecting and Studying Blood and Tissue Samples From Patients With Locally Recurrent or Metastatic Prostate or Bladder/Urothelial Cancer |
https://ClinicalTrials.gov/show/NCT01050504 |
Recruiting |
University of Washington |
2021-09-01 |
| NCT01015963 |
Studying DNA in Tissue Samples From Caucasian and African-American Cancer Patients Who Received Docetaxel on Clinical Trial CLB-9871 |
https://ClinicalTrials.gov/show/NCT01015963 |
Completed |
Alliance for Clinical Trials in Oncology |
2013-01-31 |
| NCT01007058 |
Markers of Response to Intravesical Bladder Cancer Therapy |
https://ClinicalTrials.gov/show/NCT01007058 |
Completed |
M.D. Anderson Cancer Center |
2016-04-30 |
| NCT00903240 |
Observational Study of Subjects Having Routine Recurrence Screening for Bladder Cancer |
https://ClinicalTrials.gov/show/NCT00903240 |
Completed |
Predictive Biosciences |
2010-04-30 |
| NCT00902590 |
A Genotype-Phenotype Urothelial Cancer Registry |
https://ClinicalTrials.gov/show/NCT00902590 |
Recruiting |
Memorial Sloan Kettering Cancer Center |
2023-05-31 |
| NCT00900276 |
Biomarkers in Patients With Kidney Cancer or Cancer of the Urothelium and in Healthy Participants |
https://ClinicalTrials.gov/show/NCT00900276 |
Completed |
Wake Forest University Health Sciences |
2011-04-30 |
| NCT00872495 |
Evaluation of Non-Invasive Assays for the Detection of Urothelial Cancer |
https://ClinicalTrials.gov/show/NCT00872495 |
Active, not recruiting |
Lahey Clinic |
2025-10-31 |
| NCT00871754 |
Molecular Analysis Of Bladder Cancer |
https://ClinicalTrials.gov/show/NCT00871754 |
Active, not recruiting |
Lahey Clinic |
2020-12-31 |
| NCT00848627 |
Screening for Bladder Cancer |
https://ClinicalTrials.gov/show/NCT00848627 |
Completed |
Baylor College of Medicine |
2012-01-31 |
| NCT00848289 |
Genetic Susceptibility to Bladder Cancer |
https://ClinicalTrials.gov/show/NCT00848289 |
Recruiting |
M.D. Anderson Cancer Center |
2024-08-31 |
| NCT00829920 |
The Effect of Treatment on Circulating Tumor Cells in Bladder Cancer Patients With Muscle-invasive or Advanced Disease |
https://ClinicalTrials.gov/show/NCT00829920 |
Completed |
University of Colorado, Denver |
2012-11-30 |
| NCT01637935 |
Cohort Study of Pioglitazone and Bladder Cancer in Patients With Type II Diabetes |
https://ClinicalTrials.gov/show/NCT01637935 |
Completed |
Takeda |
2014-08-31 |
| NCT01395225 |
Lymph Node Processing Protocol for Radical Cystectomy and Pelvic Lymph Node Dissection in Bladder Cancer |
https://ClinicalTrials.gov/show/NCT01395225 |
Completed |
University of British Columbia |
2013-04-30 |
| NCT00801762 |
Fiber-Optic Confocal Microscopy of the Urinary Tract Histopathology |
https://ClinicalTrials.gov/show/NCT00801762 |
Completed |
Stanford University |
2015-02-28 |
| NCT00342875 |
The New England Bladder Cancer Study |
https://ClinicalTrials.gov/show/NCT00342875 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT00001823 |
Evaluation for NCI Surgery Branch Clinical Research Protocols |
https://ClinicalTrials.gov/show/NCT00001823 |
Recruiting |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT03121768 |
A New Prognostic Model for Predicting the Outcome of Patients With Non-muscle Invasive Bladder Cancer (NMIBC) |
https://ClinicalTrials.gov/show/NCT03121768 |
Recruiting |
Mansoura University |
2019-12-01 |
| NCT03664258 |
A Multi-National Study In Bladder Cancer Patients to Detect Recurrences After TURB (Trans-urethral Resection of the Bladder) Earlier With the Xpert Bladder Cancer Monitor Assay (ANTICIPATE X) |
https://ClinicalTrials.gov/show/NCT03664258 |
Recruiting |
Cepheid |
2021-06-30 |
| NCT03499782 |
Precise Treatment System of Biliary Malignancies Based on Special Disease Database |
https://ClinicalTrials.gov/show/NCT03499782 |
Recruiting |
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine |
2021-08-31 |
| NCT00776178 |
Follow-Up of Bladder Cancer Patients From the New England Study of Environment and Health |
https://ClinicalTrials.gov/show/NCT00776178 |
Completed |
National Institutes of Health Clinical Center (CC) |
2020-03-31 |
| NCT00772018 |
Quality of Life and Symptom Management in Patients With Bladder Cancer |
https://ClinicalTrials.gov/show/NCT00772018 |
Completed |
Baylor College of Medicine |
2010-09-30 |
| NCT00744744 |
Health-Related Quality of Life in Patients With Bladder Cancer |
https://ClinicalTrials.gov/show/NCT00744744 |
Completed |
Baylor College of Medicine |
2011-07-31 |
| NCT00634621 |
Effectiveness of Hexaminolevulinate (Hexvix) in the Diagnosis and Treatment of Patients With Non-invasive Bladder Cancer |
https://ClinicalTrials.gov/show/NCT00634621 |
Completed |
GE Healthcare |
2010-09-30 |
| NCT00612326 |
Feasibility Evaluation of Magnetic Resonance Imaging and Positron Emission Tomography for Bladder Cancer Diagnosis and Staging |
https://ClinicalTrials.gov/show/NCT00612326 |
Completed |
Memorial Sloan Kettering Cancer Center |
2008-03-31 |
| NCT00582387 |
Genetic Susceptibility to Tumor Recurrence and Progression in Patients With Non-Muscle Invasive Bladder Cancer |
https://ClinicalTrials.gov/show/NCT00582387 |
Completed |
Memorial Sloan Kettering Cancer Center |
2013-07-31 |
| NCT00469066 |
Cone Beam CT Scanning in Lung and Bladder Cancer. |
https://ClinicalTrials.gov/show/NCT00469066 |
Completed |
AHS Cancer Control Alberta |
2009-08-31 |
| NCT00339443 |
Calibration of Urine pH Strips for NCI Case-Control Studies on Bladder Cancer and Comparison of DNA Yields From Buccal Cells Collected Through Two Different Methods |
https://ClinicalTrials.gov/show/NCT00339443 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT00318266 |
NMP22 Provides Improved Sensitivity in Detecting Bladder Cancers. |
https://ClinicalTrials.gov/show/NCT00318266 |
Completed |
Lawson Health Research Institute |
2008-05-31 |
| NCT00315653 |
Survivin Urine mRNA Assay Risk of Bladder Cancer Study |
https://ClinicalTrials.gov/show/NCT00315653 |
Completed |
Fujirebio Diagnostics, Inc. |
NA |
| NCT00310115 |
Motivational Counseling in Preventing Smoking Relapse After Pregnancy in Pregnant Women Who Quit Smoking During Pregnancy |
https://ClinicalTrials.gov/show/NCT00310115 |
Completed |
M.D. Anderson Cancer Center |
2016-08-31 |
| NCT00213655 |
URO-BCG-4 : Bladder Tumors Immunotherapy |
https://ClinicalTrials.gov/show/NCT00213655 |
Completed |
University Hospital, Rouen |
2013-05-31 |
| NCT00095589 |
Microsatellite Analysis of Urinary Sediment in Detecting Bladder Cancer |
https://ClinicalTrials.gov/show/NCT00095589 |
Completed |
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins |
2009-06-30 |
| NCT00011518 |
Bladder Cancer Case Control Study of Arsenic in Water |
https://ClinicalTrials.gov/show/NCT00011518 |
Completed |
National Institute of Environmental Health Sciences (NIEHS) |
NA |